上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。
Clofilium tosylate (Synonyms: 氯非铵甲苯磺酸盐) 纯度: ≥98.0%
Clofilium tosylate 是一种钾通道 (potassium channel) 阻滞剂,作用于人早幼粒细胞白血病 (HL-60) 细胞,激活 caspase-3 而诱导凋亡。具有抗心律失常作用。
Clofilium tosylate Chemical Structure
CAS No. : 92953-10-1
规格 | 价格 | 是否有货 | 数量 |
---|---|---|---|
10 mM * 1 mL in DMSO | ¥1210 | In-stock | |
10 mg | ¥1100 | In-stock | |
50 mg | ¥4900 | In-stock | |
100 mg | 询价 | ||
200 mg | 询价 |
* Please select Quantity before adding items.
Clofilium tosylate 相关产品
•相关化合物库:
- Bioactive Compound Library Plus
- Apoptosis Compound Library
- Membrane Transporter/Ion Channel Compound Library
- Anti-Cancer Compound Library
- Anti-Cardiovascular Disease Compound Library
- Anti-Alzheimer’s Disease Compound Library
- Anti-Blood Cancer Compound Library
- Neurodegenerative Disease-related Compound Library
生物活性 |
Clofilium tosylate, a potassium channel blocker, induces apoptosis of human promyelocytic leukemia (HL-60) cells via Bcl-2-insensitive activation of caspase-3. Antiarrhythmic agent[1]. |
IC50 & Target |
Potassium channel[1] |
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
体外研究 (In Vitro) |
HL-60 cells treated with Clofilium (0-20 μM; 24, 48, and 72 hours) lead to suppression of viability and proliferation in both time and concentration-dependent manners. Cell viability decreases significantly in HL-60 cells treated with 2.5 μM to 10 μM of Clofilium[1]. 上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only. Cell Viability Assay[1]
Western Blot Analysis[1]
|
||||||||||||||||
分子量 |
510.17 |
||||||||||||||||
Formula |
C28H44ClNO3S |
||||||||||||||||
CAS 号 |
92953-10-1 |
||||||||||||||||
中文名称 |
氯非铵甲苯磺酸盐 |
||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||
储存方式 |
4°C, sealed storage, away from moisture and light *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) |
||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : 125 mg/mL (245.02 mM; Need ultrasonic) H2O : 1.59 mg/mL (3.12 mM; ultrasonic and warming and heat to 60°C) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
|
||||||||||||||||
参考文献 |
|
所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务